FDA-approved uses of tirzepatide (Mounjaro and Zepbound): Mounjaro is an FDA-approved dual receptor agonist used to treat blood sugar levels in individuals with type 2 diabetes mellitus
Semaglutide stands out for its well-established track record in glycemic control and substantial weight loss, while Tirzepatide introduces a novel dual-action approach that holds promise for comprehensive metabolic improvements
Clinical scale: A medical-grade digital scale with high capacity (at least 600 lbs) and stadiometer for height measurement
Zepbound (tirzepatide) acts as a "dual agonist," targeting both GIP and GLP-1 pathways
National Institute For Health And Care Excellence: Semaglutide for managing overweight and obesity PubMed: Cost-effectiveness analysis of semaglutide 2.4 mg for the treatment of adult patients with overweight and obesity in the United States Business Insider: How weight-loss injections like Ozempic, Mounjaro, and triple G compare in cost, results, and effectiveness FDA Label: OZEMPIC (Semaglutide Injection) Medication Guide FDA Label: WEGOVY (Semaglutide Injection) Medication Guide FDA Label: RYBELSUS (Oral Semaglutide) Medication Guide FDA Label: MOUNJARO (Tirzepatide Injection) Medication Guide FDA Label: ZEPBOUND (Tirzepatide Injection) Medication Guide Important Medical Information and Disclaimers MEDICAL DISCLAIMER This information is for educational purposes only and is not intended as medical advice, diagnosis, or treatment recommendation
Or if you're on, say, Adderall and Ritalin or other stimulants, you can't take a stimulant, so that rules that out
